GSK drug tops NHS primary care prescription spending
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's Seretide for asthma and chronic obstructive pulmonary disease (COPD) was the biggest selling branded primary care medicine in 2014 in England and Wales, according to research from Cogora, a healthcare media and marketing service company.